These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25575707)

  • 21. Gain of virulence caused by loss of a gene in murine cytomegalovirus.
    Bubić I; Wagner M; Krmpotić A; Saulig T; Kim S; Yokoyama WM; Jonjić S; Koszinowski UH
    J Virol; 2004 Jul; 78(14):7536-44. PubMed ID: 15220428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection.
    Tang-Feldman YJ; Wojtowicz A; Lochhead GR; Hale MA; Li Y; Pomeroy C
    J Virol Methods; 2006 Feb; 131(2):122-9. PubMed ID: 16140399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection.
    Lathbury LJ; Allan JE; Shellam GR; Scalzo AA
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2605-13. PubMed ID: 8887497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine Cytomegalovirus Spread Depends on the Infected Myeloid Cell Type.
    Farrell HE; Bruce K; Lawler C; Stevenson PG
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming innate host resistance to vaccination: employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception.
    Nikolovski S; Lloyd ML; Harvey N; Hardy CM; Shellam GR; Redwood AJ
    Vaccine; 2009 Aug; 27(38):5226-32. PubMed ID: 19591797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses.
    Picarda G; Ghosh R; McDonald B; Verma S; Thiault N; El Morabiti R; Griffith TS; Benedict CA
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse model for cytomegalovirus infection.
    Brune W; Hengel H; Koszinowski UH
    Curr Protoc Immunol; 2001 Aug; Chapter 19():Unit 19.7. PubMed ID: 18432758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection.
    Riera L; Gariglio M; Valente G; Müllbacher A; Museteanu C; Landolfo S; Simon MM
    Eur J Immunol; 2000 May; 30(5):1350-5. PubMed ID: 10820381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Chemokine Receptor CXCR3 Promotes CD8
    Caldeira-Dantas S; Furmanak T; Smith C; Quinn M; Teos LY; Ertel A; Kurup D; Tandon M; Alevizos I; Snyder CM
    J Immunol; 2018 Feb; 200(3):1133-1145. PubMed ID: 29288198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA immunization confers protection against murine cytomegalovirus infection.
    González Armas JC; Morello CS; Cranmer LD; Spector DH
    J Virol; 1996 Nov; 70(11):7921-8. PubMed ID: 8892915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse cytomegalovirus lacking sgg1 shows reduced import into the salivary glands.
    Ma J; Bruce K; Stevenson PG; Farrell HE
    J Gen Virol; 2024 Aug; 105(8):. PubMed ID: 39093048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference in replication of low-passage MCMV HaNa1 in BALB/c, C57BL/6 and NOD mice and role of different branches of immunity in susceptibility.
    Xiang J; Zhang S; Leclercq G; Nauwynck H
    Virus Res; 2016 Aug; 221():38-46. PubMed ID: 27173788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus.
    Noda S; Tanaka K; Sawamura S; Sasaki M; Matsumoto T; Mikami K; Aiba Y; Hasegawa H; Kawabe N; Koga Y
    J Immunol; 2001 Mar; 166(5):3533-41. PubMed ID: 11207313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ?
    Andrews DM; Farrell HE; Densley EH; Scalzo AA; Shellam GR; Degli-Esposti MA
    J Immunol; 2001 Feb; 166(3):1796-802. PubMed ID: 11160226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.
    Dogra P; Miller-Kittrell M; Pitt E; Jackson JW; Masi T; Copeland C; Wu S; Miller WE; Sparer T
    J Gen Virol; 2016 Nov; 97(11):2957-2972. PubMed ID: 27638684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor gamma 2.
    Palmon A; Blagerman S; Tel-Or S; Pecht M; Trainin N; Burstein Y; Rager-Zisman B
    Antiviral Res; 1996 Dec; 33(1):55-64. PubMed ID: 8955853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein.
    Gorman S; Lloyd ML; Smith LM; McWhorter AR; Lawson MA; Redwood AJ; Shellam GR
    Vaccine; 2008 Jul; 26(31):3860-9. PubMed ID: 18573574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor.
    Iizuka K; Nakajima C; Iizuka YM; Takase M; Kato T; Noda S; Tanaka K; Kanagawa O
    J Immunol; 2007 Jul; 179(2):1122-8. PubMed ID: 17617605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion and Protection by a Virus-Specific NK Cell Subset Lacking Expression of the Inhibitory NKR-P1B Receptor during Murine Cytomegalovirus Infection.
    Rahim MM; Wight A; Mahmoud AB; Aguilar OA; Lee SH; Vidal SM; Carlyle JR; Makrigiannis AP
    J Immunol; 2016 Sep; 197(6):2325-37. PubMed ID: 27511735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of IL10 and NK Cells on the Susceptibility to Mouse Cytomegalovirus in BALB/c Mice despite the Compensation of IFNγ.
    Lu Y; Liu X; Huang Y; Liao Y; Xi T; Zhang Y; Shu S; Fang F
    Intervirology; 2018; 61(3):111-122. PubMed ID: 30336455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.